<DOC>
	<DOC>NCT01632059</DOC>
	<brief_summary>Examination of ADMA (Asymmetric-Dimethylarginine)-serum level and DDAH II (Dimethylarginine Dimethylaminohydrolase)- Polymorphism in patients with severe Sepsis and septic shock as prognostic value. This study looks into ADMA as a good prognostic factor for sepsis. Further more the dependency of the ADMA level to the DDAH II polymorphisms is reviewed this study.</brief_summary>
	<brief_title>Examination of ADMA Serum Level and DDAH II</brief_title>
	<detailed_description>Secondary targets are the mortality (28 days ICU), the length of hospitalisation in ICU and peripheral station, the severity of the illness (SAPS II score), the SOFA-score values in the progress and the procalcitonin values in the progress</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock, Septic</mesh_term>
	<criteria>&gt;18 y/o sepsis septical shock primary cardiogenic shock pregnancy breastfeeding non compliance moribund status</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>ADMA</keyword>
	<keyword>DDAH II</keyword>
	<keyword>SAPS</keyword>
	<keyword>SOFA</keyword>
	<keyword>Sepsis</keyword>
	<keyword>Procalcitonin</keyword>
	<keyword>ICU</keyword>
	<keyword>mortality</keyword>
	<keyword>length of stay</keyword>
</DOC>